Dr. Christine Klein studied medicine in Hamburg, Heidelberg, Luebeck, London, and Oxford. After a Neurogenetics fellowship at Harvard with Dr. X.O. Breakefield, she completed her neurology training in Luebeck in 2004, followed by summer sabbaticals with Dr. A.E. Lang in Toronto, Canada (2004-2015). She was appointed Lichtenberg Professor (2005), Schilling Professor (2009), and Director of the Institute of Neurogenetics (2013) at Luebeck University, where her research has focused on the clinical and molecular genetics of movement disorders. Dr. Klein has published >500 articles (h-factor: 118; >60,000 citations). She was President of the German Neurological Society in 2019/2020, serves as current Chair of the European Section of the Movement Disorder Society (MDS-ES), and leads the Monogenic Network of the Global Parkinson’s Genetics Program (https://gp2.org). She is a member of the National Academy of Sciences Leopoldina, and 15 of her former mentees have been promoted to the professor level.
Associated Grants
-
Establishing a Cohort of Carriers with ATP13A2 Mutations for Clinical and Biomarker Analysis
2024
-
-
Interaction of Mitochondrial Genes and Lifestyle Factors on Age at Onset in Parkinson’s Disease
2022
-
Interaction of Mitochondrial Genes and Lifestyle Factors on Age at Onset in Parkinson’s Disease
2022